The combination of biological and technical products or processes - called biohybrid - will hardly be possible in the future. This includes implants which replace damaged cells, tissues or organs with biological material or stimulate their healing: thus regenerate rather than repair. Real challenges for medical technology are also new methods for the integration of biological processes, mechanical instruments and high-tech electronics. In addition, new methods and materials for the coating and "activation" of surfaces by biological components are to be developed as part of the biohymed project. The coatings with tailor-made biomolecules or body-specific cells promise better healing and lower rejection reactions.

A further topic of the project is In vitro diagnostics. These include, for example, innovative analytical systems to quickly and reliably identify hospitals on the spot, as well as "Companion Diagnostics" and procedures for biomarker identification - ie genetic studies for individual treatment planning. For Project Leader Dr. Verena Grimm from BioRegio STERN Management GmbH, the project always focuses on patient use: "By combining biotechnology and medical technology, completely new diagnostic and therapeutic approaches are possible."


Participating companies from the STERN BioRegion: 

  • HB Technologies AG, Tübingen                  
  • Mediagnost GmbH, Reutlingen
  • PolyMedics Innovations GmbH, Denkendorf
  • 3T analytik GmbH & Co. KG, Tuttlingen
  • DNE microtechnology GmbH, Schnaittenbach
  • DTS Prototyping, Bisingen
  • EnDeCo GmbH, Grosselfingen
  • Intavis AG, Köln
  • Intuity Media Lab GmbH, Stuttgart
  • MAB Discovery GmbH, München
  • Novis GmbH, Tübingen
  • Remsgold GmbH & Co. KG, Winterbach
  • Scheerer Logistik GmbH & Co.KG, Aichhalden
  • defortec GmbH
  • Contexo GmbH
  • BioTeSys GmbH
  • Computomics GmbH

Associated Partners :

  • Verein zur Förderung der Biotechnologie und Medizintechnik e.V.
  • NMI Naturwissenschaftliche und Medizinische Institut an der Universität Tübingen
  • Medical Valley Hechingen Akademie e.V.
  • Universitätsklinik für Urologie, Eberhard-Karls-Universität Tübingen
  • DITF (Deutsches Institut für Textil und Faserforschung), Denkendorf
  • Experimentelle Chirurgische Endoskopie, Universitätsklinik Tübingen
  • Zentrum für Quantitative Biologie (QBiC), Eberhard-Karls-Universität Tübingen
  • Institut für Lebensmittelchemie und Lebensmittelbiotechnologie, Justus-Liebig-Universität Gießen
  • CeGaT GmbH, Tübingen

Contact us!

Other companies are welcome as project partners and will be supported in the framework of the project in order to be able to submit also successful applications for research and development at the ZIM.

Verena Grimm, Dr. rer. nat.

Project Management
Project Management
Verena Grimm, Dr. rer. nat.

"By participating at the trinational study course of the École supérieure de Biotechnologie de Strasbourg, I was able to gain first international study experience. After graduating with a diploma thesis in the area of Virology and Gene Therapy at the University of Michigan, I developed a DNA microarray for rapid antibiotic resistance detection during my doctorate at the Institute of Technical Biochemistry in Stuttgart. The following ten years I worked in the product and marketing management in the field of diagnostics at Greiner Bio-One GmbH, which produces multiplex analytical methods for use in food safety, human diagnostics and product safety in the pharmaceutical industry. Starting January 2017 at the BioRegio STERN Management GmbH, I will use my international experience in the development, application and marketing of biotechnological methods to network, attend and support companies in the medtech and biotech industry in the region. As project manager I support the regional companies’ prospects for automated applications and the development of new products."

Nina Zabel, M.Sc. Biology

Project Management
Project Management
Nina Zabel, M.Sc. Biology

„I completed my master’s degree in biology at the University of Hohenheim. During my internship at Greiner Bio-One GmbH, I gained a working knowledge of the operations of the various departments in the company. This gave me an understanding of the entire development process of products for specific applications in medical, pharmaceutical and biotechnological research and industry. Afterwards, I wrote my thesis at the Institute for Membrane Physiology in collaboration with Greiner Bio-One GmbH. During this time, I characterised magnetic nanoparticles, which represent a model system for creating 3D cell cultures, and investigated their influence on cellular parameters. Since February 2018, I have been working at BioRegio STERN Management GmbH, where I support the project management team on national projects.“


Biologisation of medical technology – partner companies wanted

ZIM supports new “BioHyMed” network project for developing biohybrid products